proximity ligation assay
The company is developing blood-based early detection tests for ovarian and lung cancer that measure tumor-associated proteins on extracellular vesicles.
Alamar Biosciences Raising $128M in Series C Funding Round
The company said it plans to use the funds to accelerate commercialization of its NULISA proteomic technology.
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.
Phase Genomics Wins $1.5M for Proximity Ligation-Based AMR Tracking
The funding supports development of a low-cost platform for detection of antimicrobial resistance elements in complex microbial communities.